Therapeutic potential of mesenchymal stromal/stem cells in critical-care patients with systemic inflammatory response syndrome.

Gerardo-Javier Martí-Chillón Sandra Muntión Silvia Preciado Lika Osugui Almudena Navarro-Bailón Javier González-Robledo Víctor Sagredo Juan F Blanco Fermin M Sanchez-Guijo

Published in: Clinical and translational medicine (2023)

In the current review, after briefly overviewing SIRS physiopathology, we explore the potential mechanisms why MSC therapy could aid in the recovery of this condition and the pre-clinical and early clinical evidence generated to date.

Keyphrases

stem cells
inflammatory response
bone marrow
lipopolysaccharide induced
case report
risk assessment
mesenchymal stem cells
lps induced
climate change
toll like receptor